EP 0095502 A4 19870120 - HUMAN MONOCLONAL ANTIBODIES OR LYMPHOKINES IN SEPARATION OF CELLS OR DIAGNOSIS OF MAMMARY CANCER.
Title (en)
HUMAN MONOCLONAL ANTIBODIES OR LYMPHOKINES IN SEPARATION OF CELLS OR DIAGNOSIS OF MAMMARY CANCER.
Title (de)
MENSCHLICHE MONOKLONALE ANTIKÖRPER ODER LYMPHOKINEN BEI DER ABSCHEIDUNG VON ZELLEN ODER DER DIAGNOSE VON BRUSTKREBS.
Title (fr)
ANTICORPS HUMAINS MONOCLONIQUES OU LYMPHOCINES DANS LA SEPARATION DE CELLULES OU DANS LE DIAGNOSTIC DU CANCER DU SEIN.
Publication
Application
Priority
- US 32873881 A 19811208
- US 39883982 A 19820716
Abstract (en)
[origin: WO8302058A1] Method for separating fused cells, resulting from fusion of human cells known to produce a specific antibody or a specific lymphokine with malignant human partner cells, from the said partner cells which comprises addition of specific antiserum capable of identifying antigenic specificities unique to the clone and non-reactive with the non-fused partner cells. After reaction of the fused cell with the antiserum, the reaction product is separated within 24 hours by indirect rosetting. The monoclonal antibodies may be employed in in vitro testing for malignancies.
IPC 1-7
A61K 39/395; C12N 5/00; C12N 5/02; G01N 33/48; G01N 33/50; G01N 33/54
IPC 8 full level
C12N 15/00 (2006.01); A61K 39/00 (2006.01); C07K 14/52 (2006.01); C07K 16/24 (2006.01); C07K 16/30 (2006.01); C12N 5/00 (2006.01); C12N 5/10 (2006.01); C12N 5/16 (2006.01); C12N 15/02 (2006.01); C12P 21/00 (2006.01); C12P 21/08 (2006.01); C12Q 1/04 (2006.01)
CPC (source: EP)
C07K 14/52 (2013.01); C07K 16/24 (2013.01); C07K 16/3015 (2013.01); C12N 5/163 (2013.01)
Designated contracting state (EPC)
BE CH DE FR GB LI NL SE
DOCDB simple family (publication)
WO 8302058 A1 19830623; CA 1200484 A 19860211; DK 325183 A 19830714; DK 325183 D0 19830714; EP 0095502 A1 19831207; EP 0095502 A4 19870120; JP S58502132 A 19831215
DOCDB simple family (application)
US 8201712 W 19821208; CA 417228 A 19821208; DK 325183 A 19830714; EP 83900257 A 19821208; JP 50032983 A 19821208